Arovella Therapeutics Ltd News

Arovella Therapeutics Ltd: Release of Shares from Escrow

Oct 1 10:56

Arovella Therapeutics Ltd: Notification regarding unquoted securities - ALA

Sep 19 07:54

Arovella Therapeutics Ltd: Application for quotation of securities - ALA

Sep 19 07:51

Arovella Therapeutics Ltd: Investor Webinar Presentation

Sep 18 08:30

Arovella Therapeutics Ltd: Becoming a substantial holder

Sep 18 07:09

Arovella Therapeutics Ltd: Change in substantial holding

Sep 18 07:05

Arovella Therapeutics Ltd: Updated Investor Webinar Presentation

Sep 12 15:18

Arovella Therapeutics Ltd: Investor Webinar Presentation

Sep 12 11:27

Arovella Therapeutics Ltd: 2024 ESG Report

Sep 11 08:32

Arovella Therapeutics Ltd: ALA presents at Cell and Gene Therapy World Asia Conference

Sep 10 07:58

Arovella Therapeutics Ltd: Corporate Governance Statement

Aug 22 07:46

Arovella Therapeutics Ltd: Appendix 4G

Aug 22 07:44

Arovella Therapeutics Ltd: Appendix 4E and Annual Report

Aug 22 07:43

Arovella Therapeutics Ltd: Positive pre-IND feedback from FDA for ALA-101

Aug 7 07:21

Arovella Therapeutics Ltd: Quarterly Activities/Appendix 4C Cash Flow Report

Jul 25 07:34

Arovella Therapeutics Ltd: Notice Under Section 708A

Jul 23 14:49

Arovella Therapeutics Ltd: Application for quotation of securities - ALA

Jul 23 14:47

Arovella Therapeutics Ltd: Investor Webinar Presentation

Jul 19 06:15

Arovella Therapeutics Ltd: Notice Under Section 708A

Jul 4 09:24

Arovella Therapeutics Ltd: Application for quotation of securities - ALA

Jul 4 09:13